Today: 27 April 2026
Toyota recalls 162,000 Tundra trucks in the U.S. over screen failure that can blank the backup camera
25 January 2026
1 min read

Toyota recalls 162,000 Tundra trucks in the U.S. over screen failure that can blank the backup camera

NEW YORK, January 25, 2026, 06:26 EST

  • Toyota is recalling about 162,000 2024-2025 Tundra and Tundra Hybrid pickups in the United States.
  • The multimedia display can freeze on a camera view or go black, which can block the rearview image when reversing.
  • Dealers will apply a free software update; owners are expected to be notified by late March.

Toyota is recalling about 162,000 Tundra and Tundra Hybrid pickup trucks in the United States after it found the vehicles’ multimedia display could fail in a way that affects the rearview camera image.

The issue matters because it touches a basic safety function on large pickups: the camera view drivers rely on when backing up. Toyota warned the vehicle “may not meet a federal safety standard” and said the defect can raise “an increased risk of a crash with a person behind the vehicle.”

Toyota said the recall covers certain model year 2024-2025 Tundra and Tundra Hybrid vehicles, and involves about 162,000 vehicles in the U.S. Dealers will update the Parking Assist ECU software free of charge — the ECU is an electronic control unit, one of the vehicle’s onboard computers.

Owners are expected to be notified by late March, Toyota said. Until then, the company pointed drivers to its recall website and the U.S. auto safety regulator’s recall database to check their vehicle.

Toyota said the multimedia display can “become stuck on a camera view” or show a black image under certain circumstances. If that happens, the rearview image “may not be displayed while the vehicle is being reversed,” according to the company. ABC News

The recall hits Toyota’s full-size Tundra line, a smaller player in the U.S. pickup market than Ford’s F-150, General Motors’ Chevrolet Silverado and Stellantis’ Ram 1500, but one that has been central to Toyota’s push deeper into the segment.

But Toyota did not say how often the screen failure occurs, whether it has been linked to crashes or injuries, or how many field reports it received before launching the campaign. The fix is a software update, and owner letters are not expected until late March, leaving some trucks on the road before the remedy is applied.

U.S. rules have pushed rear visibility technology into nearly every new light vehicle. A federal rule requires vehicles under 10,000 pounds manufactured on or after May 1, 2018 to come equipped with rear visibility technology, the U.S. Transportation Department has said.

Stock Market Today

  • SQM Valuation Under Scrutiny Amid New Lithium Oversupply Concerns
    April 27, 2026, 5:29 PM EDT. Sociedad Química y Minera de Chile (SQM) faces fresh lithium market oversupply concerns raised by Rothschild & Co Redburn research. Despite recent share price gains-up 7.36% in 30 days and 27.33% year-to-date-SQM trades at $88.79 against a perceived fair value of $75.33, implying a 17.9% overvaluation. Expansion plans in Australia and Chile, including projects like Salar Futuro, bolster long-term growth potential, but lithium price volatility and Chilean regulatory risks cloud the outlook. Conflicting discounted cash flow (DCF) models add uncertainty, with one suggesting an intrinsic value of $113.84, highlighting divergent investor perspectives on SQM's earnings and growth prospects in a shifting lithium market.

Latest article

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

27 April 2026
Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

27 April 2026
Rambus shares fell 10.8% to $141.31 Monday after reporting first-quarter revenue of $180.2 million and net income of $59.9 million. Product revenue rose 15% to $88 million, driven by AI data-center demand. The company forecast higher second-quarter product revenue but said results depend on customer deals. Rambus recently launched a new server memory module aimed at AI systems.
Edesa Biotech Stock Soars 54%: What’s Driving the ARDS Drug Rally Now

Edesa Biotech Stock Soars 54%: What’s Driving the ARDS Drug Rally Now

27 April 2026
Edesa Biotech shares surged 53.9% to $11.17 on Nasdaq Monday, with trading volume near 9 million shares. The spike follows renewed focus on February data showing paridiprubart cut 28-day mortality in ARDS patients to 24% from 33%. CEO Par Nijhawan and principal investigator Ted Steiner are set to present at May ATS meetings. Edesa ended last quarter with $12.1 million in cash and a $68.2 million deficit.
AMD stock closes higher into Monday as Intel stumbles; what investors watch next
Previous Story

AMD stock closes higher into Monday as Intel stumbles; what investors watch next

SLB stock price in focus: Venezuela ramp-up talk meets softer Q1 signals
Next Story

SLB stock price in focus: Venezuela ramp-up talk meets softer Q1 signals

Go toTop